Parrish R, Herschler J
Arch Ophthalmol. 1983 May;101(5):745-6. doi: 10.1001/archopht.1983.01040010745008.
A modified filtering operation for neovascular glaucoma provided control of intraocular pressure after 12 to 23 months in ten of 13 eyes. After long-term follow-up, 23 to 54 months, seven of ten eyes still had controlled IOP. Two eyes were receiving no medication, two required miotics, and three required maximal medical therapy, including carbonic anhydrase inhibitors. One eye had undergone cyclocryotherapy four years after trabeculectomy. Four of seven eyes with diabetic neovascular glaucoma retained ambulatory vision. The eye with neovascular glaucoma from central retinal vein occlusion lost useful vision. The underlying disease process is an important determinant of surviving visual function.
一种针对新生血管性青光眼的改良滤过手术，在13只眼中的10只眼，于12至23个月后实现了眼压控制。经过23至54个月的长期随访，10只眼中的7只眼眼压仍得到控制。2只眼无需用药，2只眼需要缩瞳剂，3只眼需要最大剂量的药物治疗，包括碳酸酐酶抑制剂。1只眼在小梁切除术后四年接受了睫状体冷凝术。7只糖尿病性新生血管性青光眼中有4只保留了可走动状态下的视力。因视网膜中央静脉阻塞导致新生血管性青光眼的那只眼丧失了有用视力。潜在的疾病进程是视觉功能存活的重要决定因素。
